Now showing items 1-3 of 3

    • Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-07-07)
      The disclosed invention relates to the use of perlecan domain V (DV) for the treatment of stroke, traumatic brain injury (TBI) or spinal cord injuries (SCI). In certain embodiments, fusion proteins of DV can be used for ...
    • Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-06-18)
      The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin ...
    • Bix, Gregory J.; Wright, Sarah; Griswold-prenner, Irene (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-06-07)
      The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related ...